{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:50:25Z","timestamp":1790041825844,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04709-9","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:05:36Z","timestamp":1768583136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment patterns, clinical outcomes, and economic burden among patients with immunoglobulin A nephropathy (IgAN) in China"],"prefix":"10.1186","volume":"27","author":[{"given":"Youxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasikiran","family":"Nunna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiekun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"4709_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai KN, Tang SCW, Schena FP, Novak J, Tomino Y, Fogo AB, et al. IgA nephropathy. Nat Rev Dis Primers. 2016;2:1\u201320. https:\/\/doi.org\/10.1038\/nrdp.2016.1.","journal-title":"Nat Rev Dis Primers"},{"key":"4709_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00281-021-00884-7","volume":"43","author":"H Zhang","year":"2021","unstructured":"Zhang H, Barratt J. Is IgA nephropathy the same disease in different parts of the world? Semin Immunopathol. 2021;43:707\u201315. https:\/\/doi.org\/10.1007\/s00281-021-00884-7.","journal-title":"Semin Immunopathol"},{"key":"4709_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","volume":"38","author":"FP Schena","year":"2018","unstructured":"Schena FP, Nistor I. Epidemiology of IgA nephropathy: A global perspective. Semin Nephrol. 2018;38:435\u201342. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.013.","journal-title":"Semin Nephrol"},{"key":"4709_CR4","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/j.ekir.2024.11.510","volume":"10","author":"Z Chen","year":"2025","unstructured":"Chen Z, Zhang Y, Lu W, Kou J, Zhu J, Gandhi HK, et al WCN25-52 Epidemiology of immunoglobulin a nephropathy (igan) and occurrence of proteinuria in china: evidence from systematic review and meta-analysis. Kidney Int Rep. 2025;10:S276. https:\/\/doi.org\/10.1016\/j.ekir.2024.11.510.","journal-title":"Kidney Int Rep"},{"key":"4709_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-Term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18:727. https:\/\/doi.org\/10.2215\/CJN.0000000000000135.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4709_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(23)02843-X","volume":"403","author":"K Wong","year":"2024","unstructured":"Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N, et al. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National registry of rare kidney diseases (RaDaR) cohort. Lancet. 2024;403:1279\u201389. https:\/\/doi.org\/10.1016\/S0140-6736(23)02843-X.","journal-title":"Lancet"},{"key":"4709_CR7","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1093\/ndt\/gfy022","volume":"33","author":"J Li","year":"2018","unstructured":"Li J, Cui Z, Long J, Huang W, Wang J, Zhang H, et al. Primary glomerular nephropathy among hospitalized patients in a National database in China. Nephrol Dialysis Transplantation. 2018;33:2173\u201381.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4709_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12882-024-03555-5","volume":"25","author":"O Zaidi","year":"2024","unstructured":"Zaidi O, Du F, Tang Z, Bhattacharjee S, Pareja K. Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries. BMC Nephrol. 2024;25:136. https:\/\/doi.org\/10.1186\/s12882-024-03555-5.","journal-title":"BMC Nephrol"},{"key":"4709_CR9","doi-asserted-by":"publisher","unstructured":"Zhang L, Zhao M-H, Zuo L, Wang Y, Yu F, Zhang H et al. China Kidney Disease Network (CK-NET) 2016 Annual Data Report. Kidney Int Suppl (2011). 2020;10:e97\u2013185. https:\/\/doi.org\/10.1016\/j.kisu.2020.09.001","DOI":"10.1016\/j.kisu.2020.09.001"},{"key":"4709_CR10","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. The KDIGO 2024 Clinical Practice Guideline for the Management of IgA Nephropathy (IgAN) and IgA Vasculitis (IgAV). 2024. https:\/\/kdigo.org\/wp-content\/uploads\/2024\/08\/KDIGO-2025-IgAN-IgAV-Guideline.pdf. Accessed 7 Feb 2025."},{"key":"4709_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dialysis Transplantation. 2012;27:1479\u201385.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4709_CR12","doi-asserted-by":"publisher","unstructured":"Shen X, Chen P, Liu M, Liu L, Shi S, Zhou X, et al. Long-term outcomes of IgA nephropathy in China. Nephrol Dialysis Transplantation. 2024;gfae252. https:\/\/doi.org\/10.1093\/ndt\/gfae252.","DOI":"10.1093\/ndt\/gfae252"},{"key":"4709_CR13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.ajkd.2023.12.016","volume":"84","author":"C Tang","year":"2024","unstructured":"Tang C, Chen P, Si F-L, Lv J-C, Shi S-F, Zhou X-J, et al. Time-Varying proteinuria and progression of IgA nephropathy: A cohort study. Am J Kidney Dis. 2024;84:170\u2013e1781. https:\/\/doi.org\/10.1053\/j.ajkd.2023.12.016.","journal-title":"Am J Kidney Dis"},{"key":"4709_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3877\/cma.j.issn.2095-3216.2024.01.001","volume":"13","author":"Kidney Disease and Blood Purification Professional Committee of China Medical and Health Culture Association","year":"2024","unstructured":"Kidney Disease and Blood Purification Professional Committee of China Medical and Health Culture Association. Chinese expert consensus on the management and treatment of primary IgA nephropathy. Chin J Kidney Disease Invest (Electronic Edition). 2024;13:1. https:\/\/doi.org\/10.3877\/cma.j.issn.2095-3216.2024.01.001.","journal-title":"Chin J Kidney Disease Invest (Electronic Edition)"},{"key":"4709_CR15","doi-asserted-by":"publisher","unstructured":"Dong Y, Shi S, Liu L, Zhou X, Lv J, Zhang H. Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy. Front Med. 2023;10. https:\/\/doi.org\/10.3389\/fmed.2023.1242241.","DOI":"10.3389\/fmed.2023.1242241"},{"key":"4709_CR16","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhang Y, Yang C, Duan Y, Jiang L, Jin D et al. Naoxintong capsule delay the progression of diabetic kidney disease: A real-world cohort study. Front Endocrinol. 2022;13.","DOI":"10.3389\/fendo.2022.1037564"},{"key":"4709_CR17","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/ndt\/gfac004","volume":"37","author":"B Yu","year":"2022","unstructured":"Yu B, Shi S, Lv J, Liu L, Zhou X, Zhu L, et al. Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 guideline. Nephrol Dialysis Transplantation. 2022;37:2429\u201337.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4709_CR18","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1159\/000525001","volume":"146","author":"R Ebbestad","year":"2022","unstructured":"Ebbestad R, Sanaei Nurmi M, Lundberg S. Long-Term outcomes of patients with IgA nephropathy categorized by the international IgAN risk prediction tool and by the degree of hematuria at diagnosis. Nephron Clin Pract. 2022;146:573\u201383. https:\/\/doi.org\/10.1159\/000525001.","journal-title":"Nephron Clin Pract"},{"key":"4709_CR19","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1001\/jama.2022.5368","volume":"327","author":"J Lv","year":"2022","unstructured":"Lv J, Wong MG, Hladunewich MA, Jha V, Hooi LS, Monaghan H, et al. Effect of oral Methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2022;327:1888\u201398. https:\/\/doi.org\/10.1001\/jama.2022.5368.","journal-title":"JAMA"},{"key":"4709_CR20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, et al. Effect of oral Methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA. 2017;318:432\u201342. https:\/\/doi.org\/10.1001\/jama.2017.9362.","journal-title":"JAMA"},{"key":"4709_CR21","doi-asserted-by":"publisher","first-page":"e2254054","DOI":"10.1001\/jamanetworkopen.2022.54054","volume":"6","author":"FF Hou","year":"2023","unstructured":"Hou FF, Xie D, Wang J, Xu X, Yang X, Ai J, et al. Effectiveness of mycophenolate mofetil among patients with progressive IgA nephropathy: A randomized clinical trial. JAMA Netw Open. 2023;6:e2254054\u20132254054. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.54054.","journal-title":"JAMA Netw Open"},{"key":"4709_CR22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2215\/CJN.0000000000000215","volume":"18","author":"H Zhao","year":"2023","unstructured":"Zhao H, Li Y, Sun J, Xu G, Wang C, Zhou S, et al. Immunosuppression versus supportive care on kidney outcomes in IgA nephropathy in the Real-World setting. Clin J Am Soc Nephrol. 2023;18:1186. https:\/\/doi.org\/10.2215\/CJN.0000000000000215.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4709_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.05.031","author":"T Rauen","year":"2024","unstructured":"Rauen T, Vogt K, Seikrit C. Corticosteroids in patients with IgA nephropathy: is the lower the better? Kidney Int Rep. 2024. https:\/\/doi.org\/10.1016\/j.ekir.2024.05.031. 9:1966.","journal-title":"Kidney Int Rep"},{"key":"4709_CR24","doi-asserted-by":"publisher","first-page":"S385","DOI":"10.1016\/j.jval.2023.03.2159","volume":"26","author":"M Kroes","year":"2023","unstructured":"Kroes M, Aldworth C, George A, Ndife B, Prieto L, Lafayette R, et al. RWD130 differences in healthcare resource utilization for the management of Immunoglobulin a nephropathy in Europe, the US, China and Japan. Value Health. 2023;26:S385. https:\/\/doi.org\/10.1016\/j.jval.2023.03.2159.","journal-title":"Value Health"},{"key":"4709_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3969\/j.issn.1671-4091.2023.05.001","volume":"22","author":"Chinese Hospital Association Blood Purification Center Branch","year":"2023","unstructured":"Chinese Hospital Association Blood Purification Center Branch. Investigation and analyses on the peritoneal Dialysis fees and the reimbursement from medical insurance in Chinese Mainland [in Chinese]. Chin J Blood Purif. 2023;22:321\u20136. https:\/\/doi.org\/10.3969\/j.issn.1671-4091.2023.05.001.","journal-title":"Chin J Blood Purif"},{"key":"4709_CR26","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.ajkd.2019.02.016","volume":"74","author":"T Chen","year":"2019","unstructured":"Chen T, Li X, Li Y, Xia E, Qin Y, Liang S, et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am J Kidney Dis. 2019;74:300\u20139. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.016.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04709-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04709-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:04:22Z","timestamp":1770771862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04709-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4709"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04709-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethical approval from the Institutional Review Board of Tianjin Medical University General Hospital (approval number: IRB2024-YX-304-01) with a waiver of informed consent. This study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}